TRV GP III, LLC Holdings

TRV GP III, LLC is an investment fund managing more than 229.02M US dollars. The largest holdings include Pliant Therapeutics, Revolution Medicines and Voyager Therapeutics. In Q1 2021 the fund bought assets of total value of 35.67M US dollars and sold assets of total value of 501.27M US dollars.

$229.01M

portfolio value

+35.43%

quarter

-28.09%

1 year

-119.12%

3 years

TRV GP III, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2018	122745000	55463000
Q3 2020	638673000	5653000
Q1 2021	35667000	501271000

TRV GP III, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 35.02% Portfolio value: 80.2M Avg. open price: N/A Current price: $17.83 P/L: N/A Sold -34.25% shares Q3 2022	share	35.02%	80.2M	N/A	$17.83	N/A	Sold -34.25% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 31.03% Portfolio value: 71.07M Avg. open price: N/A Current price: $25.53 P/L: N/A Sold -29.39% shares Q3 2022	share	31.03%	71.07M	N/A	$25.53	N/A	Sold -29.39% shares Q3 2022
Biotechnology Voyager Therapeutics, Inc. Portfolio share: 14.03% Portfolio value: 32.13M Avg. open price: N/A Current price: $6.45 P/L: N/A Sold -15.06% shares Q3 2022	share	14.03%	32.13M	N/A	$6.45	N/A	Sold -15.06% shares Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 14.00% Portfolio value: 32.05M Avg. open price: N/A Current price: $6.75 P/L: N/A Sold -20.15% shares Q4 2021	share	14.00%	32.05M	N/A	$6.75	N/A	Sold -20.15% shares Q4 2021
Biotechnology Decibel Therapeutics, Inc. Portfolio share: 4.74% Portfolio value: 10.86M Avg. open price: N/A Current price: $3.13 P/L: N/A N/A Q1 2021	share	4.74%	10.86M	N/A	$3.13	N/A	N/A Q1 2021
Biotechnology Jounce Therapeutics, Inc. Portfolio share: 1.17% Portfolio value: 2.68M Avg. open price: N/A Current price: $0.9 P/L: N/A Sold -62.32% shares Q4 2021	share	1.17%	2.68M	N/A	$0.9	N/A	Sold -62.32% shares Q4 2021
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.61 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$12.61	N/A	Sold -100.00% shares Q3 2022

Showing TOP 7 TRV GP III's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of TRV GP III, LLC?

The biggest position of the TRV GP III, LLC is Pliant Therapeutics, Inc. (PLRX) with 35.02% portfolio share worth of 80.2M US dollars.

Top 5 TRV GP III's holdings represent 98.83% of the portfolio:

Pliant Therapeutics, Inc. (PLRX) – 35.02%
Revolution Medicines, Inc. (RVMD) – 31.03%
Voyager Therapeutics, Inc. (VYGR) – 14.03%
Fulcrum Therapeutics, Inc. (FULC) – 14%
Decibel Therapeutics, Inc. (DBTX) – 4.74%

Who is the portfolio manager of TRV GP III, LLC?

The portfolio manager of the TRV GP III, LLC is .

What is the total asset value of the TRV GP III, LLC portfolio?

TRV GP III, LLC total asset value (portfolio value) is 229.02M US dollars.

Who is ?

is the portfolio manager of the TRV GP III, LLC.

What is (TRV GP III, LLC) fund performance?

TRV GP III's quarterly performance is +35.43%, annualy -28.09%. In the past 3 years, the value of 's portfolio has decreased by -119%.

What is the TRV GP III, LLC CIK?

TRV GP III's Central Index Key is 0001637299 .